Related Experiment Video
Updated: Feb 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Concurrent Acute Ischemic Stroke and Acute Coronary Syndrome: A Case Report on Sequential Endovascular Intervention
Han Luo1, Zengxia Zhao1, Yongzhen Chen1
1Department of Neurology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, People's Republic of China.
Insights
This case study details a rare dual diagnosis of internal carotid artery occlusion ischemic stroke and acute coronary syndrome. A successful sequential treatment involving coronary intervention, carotid stenting, and thrombectomy led to a favorable outcome.
Area of Science:
- Cardiology
- Neurology
- Vascular Surgery
Background:
- Coexistence of internal carotid artery occlusion ischemic stroke and acute coronary syndrome is clinically rare.
- Managing these dual conditions presents significant therapeutic challenges.
Abstract:
Cases involving both cerebral infarction due to internal carotid artery occlusion and acute coronary syndrome are clinically rare and challenging to treat. A 50-year-old male patient was admitted to the hospital due to coexistence of internal carotid artery occlusion ischemic stroke and acute coronary syndrome. After coronary angiography and percutaneous coronary intervention (PCI), immediately perform cerebral angiography, followed by right internal carotid artery occlusion balloon dilation and stent formation, intracranial artery thrombectomy, and complete recovery of cerebral blood flow. His condition improved significantly after 15 days, and the weakness of the left limbs and alalia improved a lot. The patient who was followed up for 1 years had stable conditions and was able to take care of himself, with an mRS score of 1. Patients with acute cerebral infarction typically receive rt-PA treatment within 4.5 hours. If head and neck CTA reveals occlusion of a large artery, endovascular therapy can be used as a bridge. The therapeutic sequence of coronary stenting followed by endovascular thrombectomy and carotid artery stenting may have been critical to the patient's favorable clinical outcome. While Antiplatelet aggregation is crucial during the perioperative period of carotid artery stenting or/and coronary stent implantation, its initiation within 24 hours of intravenous thrombolysis must balance efficacy against bleeding risk. Tirofiban represents a potential option during this high-risk period.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome III: Diagnostic Studies

